Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.99
22.08.22
-
22.08.23
-7.04%
04.09.22

Could be very worthwhile Investment >20% year
buy
Mediwound Ltd.

Start price
Target price
Perf. (%)
€1.99
22.08.22
€4.00
22.08.23
-7.04%
04.09.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.70
21.08.22
-
21.08.23
-21.03%
27.02.23

buy
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€76.50
21.08.22
€230.00
21.08.23
6.54%
04.09.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€214.90
21.08.22
€87.00
21.08.23
-3.44%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Invitae Corp

Start price
Target price
Perf. (%)
€3.50
21.08.22
€1.00
21.08.23
-21.28%
04.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€214.90
20.08.22
-
20.08.23
-14.30%
07.03.23

buy
Poxel S.A.

Start price
Target price
Perf. (%)
€2.49
20.08.22
-
20.08.23
-75.54%
07.06.23

Could be worthwhile Investment >10% per year
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€61.00
20.08.22
€25.00
20.08.23
6.62%
03.09.22

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€61.00
20.08.22
€87.00
10.11.23
-6.33%
31.10.23

Mediwound Ltd.

Start price
Target price
Perf. (%)
€2.00
19.08.22
-
19.08.23
470.00%
08.01.23

Risky Investment
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€65.08
19.08.22
-
19.08.23
7.28%
20.08.23

buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€17.50
19.08.22
-
19.08.23
-4.00%
26.08.22

Could be very worthwhile Investment >20% year
buy
Bavarian Nordic A/S

Start price
Target price
Perf. (%)
€48.38
19.08.22
€51.00
19.08.23
-60.85%
20.08.23

buy
CorMedix Inc

Start price
Target price
Perf. (%)
€3.99
19.08.22
€7.00
19.08.23
-12.17%
04.09.22

buy
Global Blood Therapeutics Inc

Start price
Target price
Perf. (%)
€66.40
18.08.22
-
18.08.23
3.22%
19.08.23

buy
Curis Inc.

Start price
Target price
Perf. (%)
€1.28
18.08.22
-
18.08.23
-21.27%
20.08.22

buy
Invitae Corp

Start price
Target price
Perf. (%)
€3.80
18.08.22
-
18.08.23
-7.92%
20.08.22

buy
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.29
18.08.22
-
18.08.23
-33.11%
20.08.22

buy
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.29
18.08.22
€7.00
18.08.23
-33.11%
22.08.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth >5% per year expected
buy
Chembio Diagnostics Inc.

Start price
Target price
Perf. (%)
€0.85
18.08.22
€1.00
01.09.22
-29.84%
01.09.22

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€82.57
17.08.22
-
17.09.22
-0.75%
18.09.22

buy
Viatris Inc.

Start price
Target price
Perf. (%)
€10.85
16.08.22
-
16.08.23
2.45%
10.11.22

buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€106.80
16.08.22
-
16.08.23
-2.62%
16.08.23

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€24.20
16.08.22
-
16.08.23
-4.96%
16.08.23